← Back to Explore
NationalNational

Market context for this story

Loading quotes…

Informational only — not investment advice. Full markets →

Insider Moves: Artiva Biotherapeutics ($ARTV) — Director Receives Stock Award
Photo: Alesia Kozik / Pexels · Pexels

Insider Moves: Artiva Biotherapeutics ($ARTV) — Director Receives Stock Award

Share

💡 - The stock award (code A) is a compensation event, not a cash buy — no direct bullish or bearish signal from this transaction. - No ticker symbol was disclosed, so traders cannot directly gauge market price action around this insider move. - Watch for subsequent open-market purchases (code P) from insiders, which would indicate management's confidence in the company's prospects. - Without a ticker, avoid trading decisions based solely on this filing; seek other catalysts like clinical trial data or earnings reports.

Artiva Biotherapeutics, Inc. ($ARTV) filed a Form 4 with the SEC on July 23, 2026, detailing a stock award to a director. The transaction, coded as an award rather than an open-market purchase, does not directly signal insider conviction but adds to insider holdings.

(1) The trade — A director of Artiva Biotherapeutics received a stock award (transaction code A). The filing does not specify the number of shares or price per share. Code A indicates the insider was granted equity, not that they bought shares on the open market.

(2) Who — The insider is a director of Artiva Biotherapeutics, Inc., the issuer based in the United States.

(3) Ticker — The ticker symbol is not explicitly provided in the structured facts. Based on the company name and SEC filings, the ticker is not given; therefore, no symbol can be confirmed. For reference, the issuer's SEC CIK is 0001817241.

(4) Signal read — Because this is a grant (code A), it does not reflect an insider's discretionary purchase or sale. Awards are typically compensation or incentive-based and carry less market-moving signal than open-market buys or sales.

(5) What to watch — No cluster buying or unusual insider activity is indicated. Investors should monitor future Form 4 filings for open-market purchases (code P) or sales (code S) by directors or officers, which could offer stronger conviction signals.

Read the full story

Original reporting and related coverage — attribution links only, not paid recommendations.

Discuss this story

Trade this story

  • Robinhood logo
  • Webull logo
  • TradingView logo

Broker buttons use invite / refer-a-friend links (rewards may be capped). Other partner links may pay OppHub America a commission at no extra cost to you.

Curated tools and reads — shopping here helps keep OppHub America free.

Playbook

New stories get a playbook when they publish. Older articles may not have one yet.

No stored playbook for this article. Going forward, playbooks are generated once at publish and kept on the story.

Loading comments...
Share

Follow OppHub America for more money news